Drugmaker Apotex accuses Amarin of Vascepa monopoly in US lawsuit
WESTON, Fla., May 14, 2024 /PRNewswire/ - Apotex Corp. announced today the launch of Cetrorelix Acetate for Injection 0.25mg, a generic version of Cetrotide® in the United States.
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
Enforcement Report - Week of February 28, 2024
Apotex`s Generic Apixaban Receives Approval in the U.S.
Apotex`s Generic Macitentan Receives Approval in the U.S.
Apotex`s Generic Nilotinib Hydrochloride Receives Approval in the U.S.
Enforcement Report - Week of December 6, 2023
Apotex`s Generic Teriparatide Receives Approval in the U.S.
Enforcement Report - Week of June 14, 2023